U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07121127) titled 'Effect of Fu's Subcutaneous Needling for Age-related Macular Degeneration' on Aug. 01.
Brief Summary: This pilot randomized controlled trial aims to evaluate the efficacy and safety of FSN in improving symptoms in patients with dAMD.38 eligible participants will be recruited and randomly assign them in a 1:1 ratio to the FSN group and the control group. Throughout the study, both groups will take oral vitamin C and vitamin E supplements for a total of 28 days. Participants in the FSN group will receive four treatment sessions over two weeks. Both groups will be assessed at the end of the FSN treating period during the mid-study peri...